Medicine News and Research

RSS

No significant difference between safety-net, non-safety-net hospitals in emergency patient's length of stay

Time can be important in an emergency department especially in a busy Level 1 Trauma Center like MetroHealth Medical Center in Cleveland, when getting patients appropriate care is essential. However, when the quality of an emergency department is judged by a patient's length of stay, time takes on a new meaning.

1 Feb 2012

First signs of atherosclerotic heart disease may appear in early childhood

When we think about people with heart disease we usually think about middle-aged men. In reality, atherosclerotic heart disease is the leading cause of death for men and women in North America, but its impact starts much earlier than adulthood. Though children will rarely, if ever, have overt symptoms of atherosclerosis, the first signs of this disease appear in early childhood and perhaps even before birth.

1 Feb 2012

Study reveals substantial differences in rates of follow-up surgeries after partial mastectomy

A new study reveals substantial differences - by both surgeon and institution - in the rates of follow-up surgeries for women who underwent a partial mastectomy for treatment of breast cancer.

1 Feb 2012

GSA's new resources address pain management, labeling changes for acetaminophen

The pain suffered by older adults is the shared focus of the two newest entries in The Gerontological Society of America's (GSA) From Publication to Practice series.

1 Feb 2012

Canadian Government announces investment in personalized medicine

The Harper Government today announced an important investment that will help Canadians in getting more effective treatments and make the healthcare system more sustainable through personalized medicine.

1 Feb 2012

Decaffeinated coffee may improve brain energy metabolism linked with type 2 diabetes

Researchers from Mount Sinai School of Medicine have discovered that decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes.

1 Feb 2012

BU scientists create unique material and drug delivery mechanism

Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.

1 Feb 2012

Researchers use liquid laser to diagnose genetic mutations linked with cancer

Using a liquid laser, University of Michigan researchers have developed a better way to detect the slight genetic mutations that might predispose a person to a particular type of cancer or other diseases.

1 Feb 2012

OPN-305 may improve survival outcomes for kidney transplant patients

New research published online in the FASEB Journal details a new antibody, called "OPN-305" that may significantly improve survival outcomes for those receiving donated kidneys and other organs.

1 Feb 2012

Peptides linked with internal flu viral structures can help develop universal vaccine

Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu.

1 Feb 2012

Opinion pieces, blog react to new public-private NTD initiative

Pharmaceutical company heads and global health leaders gathered at a conference on Monday in London to announce the formation of a large public-private partnership to fight neglected tropical diseases (NTDs) and endorse the "London Declaration on Neglected Tropical Diseases", in which they pledged to work together and track progress.

1 Feb 2012

Reference book on methods and approaches in injury research

Two esteemed researchers in the field of injury research have published the most comprehensive reference book to date on the methods and approaches underpinning the scientific discipline of injury control and prevention.

1 Feb 2012

Majority of children can safely quit anti-rejection drugs after liver transplant from parents

Physicians at three transplant centers have found in a pilot study that a majority of children who receive liver tissue from a parent can eventually stop using immunosuppression (anti-rejection) medications safely. These drugs, which tamp down natural immune function, have been linked to a bevy of complications, including cancer, diabetes, hypertension and kidney failure.

1 Feb 2012

TGen, UA receive NFCR grant to study targeted pancreatic cancer therapies

The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from the National Foundation for Cancer Research.

1 Feb 2012

Study demonstrates safety of weight reduction surgery in morbidly obese adolescents

Today, about one in five children in the United States are obese. That means that in just one generation alone the number of obese kids in this country has quadrupled.

1 Feb 2012

FDA clears Toshiba's Aquilion PRIME CT system

Toshiba America Medical Systems, Inc. announces the FDA clearance of the Aquilion PRIME CT system, the latest addition to the Aquilion CT product line and part of the "ONE Family" of CT scanners.

1 Feb 2012

Potential way to block second wave of death from pneumonia treatment

An international research team may have found a way to block a second wave of death that can result from pneumonia treatment.

1 Feb 2012

Preliminary results from CINJ's Celebrex and Lipitor Phase II combination trial on prostrate cancer

Research from The Cancer Institute of New Jersey (CINJ) on the FDA-approved drugs Celebrex and Lipitor -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer.

1 Feb 2012

Dana-Farber receives MLSC grant to expand cancer imaging research

The Massachusetts Life Sciences Center has awarded Dana-Farber Cancer Institute a $10 million grant to support the expansion of its pioneering cancer imaging research program.

1 Feb 2012

Specific gene mutation triggers development of NAFLD

A team of scientists from the University of Utah and the University of California at San Francisco has discovered that the mutation of a gene encoding a ketone body transporter triggers accumulation of fat and other lipids in the livers of zebrafish.

1 Feb 2012